Reverse iontophoresis: Monitoring prostaglandin E2 associated with cutaneous inflammation in vivo

Experimental Dermatology

Volumn 6, Issue 6, 1997, Pages 298-302

  Mize, Nancy K ^a   Buttery, Margaret ^a   Daddona, Peter ^a   Morales, Claudia ^a   Cormier, Michel ^a  

^a ALZA CORPORATION   (United States)

Author keywords

Chlorpromazine; Inflammation; Iontophoresis; Prostaglandin E2; Reverse iontophoresis

Indexed keywords

CHLOROQUINE; CHLORPROMAZINE; METOCLOPRAMIDE; PROMAZINE; PROSTAGLANDIN E2; TETRACAINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GUINEA PIG; INFLAMMATION; IONTOPHORESIS; NONHUMAN; PROSTAGLANDIN SYNTHESIS; SKIN ALLERGY; SKIN INFLAMMATION; SKIN IRRITATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030659410     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1997.tb00176.x     Document Type: Article

References (20)

1. Draize J H, Woodard G, Calvery H O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1994: 82: 377-390.
2. Barr R M, Brain S, Camp R D R et al. Levels of arachidonic acid and its metabolites in the skin in human and irritant contact dermatitis. Br J Dermatol 1984: III: 23-28.
3. Camp R D R, Greaves M W. Inflammatory mediators in the skin. Br Med Bull 1987: 43(2): 401-414.
4. Greaves M W, Camp R D R. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin. Arch Dermatol Res 1988: 280: S33-S41.
5. Rao G, Glikfeld P, Guy R H. Reverse iontophoresis: development of a noninvasive approach for glucose monitoring. Pharm Res 1993: 10(12): 1751-1755.
6. Rao G, Tamada J, Azimi N et al. Iontophoretic and noninvasive glucose monitoring. Proc Intern Symp Control Rel Bioact Mater 1994: 21: 13-14.
7. Cormier M, Ledger P W, Johnson J, Phipps J B, Chao S. Reduction of skin irritation and resistance during electrotransport U.S. patent 5, 624, 415. April 29, 1997.
8. Numajiri S, Sugibayashi K, Morimoto Y. Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard. J Pharm Biomed Anal 1993: 11(10): 903-909.
9. Seitz J C, Whitmore C G. Measurement of erythema and tanning responses in human skin using a tri-stimulus colorimeter. Dermatologica 1988: 177: 70-75.
10. Wilhelm K P, Maibach H I. Skin color reflectance measurements for objective quantification of erythema in human beings. J Am Acad Dermatol 1989: 21(6): 1306-1308.
11. Wilhelm K P, Surber C, Maibach H. Quantification of sodium lauryl sulfate irritant dermatitis in man: Comparison of four techniques: skin color (reflectance, transepidermal water loss, laser Doppler flow measurement and visual scores. Arch Dermatol Res 1989: 281: 293-295.
12. Bjerrring P, Anderson P H. Skin reflectance spectrophotometry. Photodermatology 1987: 4: 167-171.
13. Greaves M W, Sondergaard J S. Continuous skin perfusion in vivo as a method for study of pharmacological agents in human skin. Acta Derm Venereol (Stockh) 1971: 51: 50-54.
14. 2a in human skin following ultraviolet B irradiation. J Clin Pharmacol 1980: 10: 453-457.
15. Basran G S, Morley J, Paul W, Turner-Warwick M. Evidence in man of synergistic interaction between putative mediators of acute inflammation in asthma. 1982: Lancet: I: 935-937.
16. 1a and histamine in human skin following ultraviolet A irradiation. J Invest Dermatol 1983: 80: 496-498.
17. Williams T J, Peck M J. Role of prostaglandin-mediated vasodilation inflammation. Nature 1977: 270: 530-532.
18. Arturson G, Hamberg M, Jonsson C-E. Prostaglandins in human burn blister fluid. Acta Physiol Scand 84: 270-276.
19. Sondergaard J, Greaves M W, Jorgensen H P. Recovery of prostaglandins in human primary irritant dermatitis. Arch Dermatol 1974: 110: 556-558.
20. Plummer N A, Hensby C N, Kobza Black A, Greaves M W. Prostaglandin activity in sustained inflammation of human skin before and after aspirin. Clin Sci Mol Med 1977: 52: 615-620.